Nome Químico: 2,5-dimethyl-1-propyl-3-(o-tolyl)imidazolidin-4-one hydrochloride
Sorrisos: CC(N(C1C)CCC)N(C(C=CC=C2)=C2C)C1=O.Cl
Inchi: InChI=1S/C29H42NO7.C2HF3O2/c1-30(14-12-29(32)37-16-8-6-7-15-31)13-11-22-19-27(35-4)28(36-5)20-23(22)24(30)17-21-9-10-25(33-2)26(18-21)34-3;3-2(4,5)1(6)7/h9-10,18-20,24,31H,6-8,11-17H2,1-5H3;(H,6,7)/q+1;/p-1/t24-,30-;/m1./s1
Liquid–Liquid Miscibility Gaps in Drug–Water Binary Systems: Crystal Structure and Thermodynamic Properties of Prilocaine and the Temperature–Composition Phase Diagram of the Prilocaine–Water System
Ivo B. Rietveld, Marc-Antoine Perrin, Siro Toscani, Maria Barrio, Beatrice Nicolai, Josep-Lluis Tamarit, and René Ceolin
Mol. Pharmaceutics 2013, 10, 4, 1332–1339
LC Determination of Lidocaine and Prilocaine Containing Potential Risky Impurities and Application to Pharmaceuticals
Mohammad Abdul-Azim Mohammad
Chromatographia volume 70, pages563–568(2009)
Determination of prilocaine HCL in bulk drug and pharmaceutical formulation by GC-NPD method
alptug atila, yucel kadioglu
Chemical Industry and Chemical Engineering Quarterly 19(2)
Simultaneous quantification of lidocaine and prilocaine in human plasma by LC-MS/MS and its application in a human pharmacokinetic study
Siva SankaraRao, Yadlapalli, Naresh KumarKatari, Surendra Babu, Manabolu Surya, Vijaya KumariKarra, VinuthaKommineni, Sreekantha B.Jonnalagadda
Practical Laboratory Medicine Volume 17, November 2019, e00129
